DeepX Health’s DermoSight^TM and skin cancer teledermatology service featured in a great BBC video interview about skin cancer prevention in people of color, as part of the BBC Morning Live program. Following the story of a patient with dark skin, who was diagnosed and successfully treated for melanoma, presenter Rhys Stephenson headed to a Boots pharmacy to have a mole scanned with DermoSight. Luckily, he was relieved to learn that he did not have melanoma, when the service sent him his diagnosis directly on his phone.

To watch the segment about the skin cancer prevention service with DermoSight available at Boots, please follow this link and tune in from 20’33”.

DermoSight is a digital dermatoscope to acquire skin lesion images for teledermatology assessment. It is currently being used in primary care, as part of NHS services in GP clinics and in community pharmacies in the UK and in Europe, including the Walgreens Boots Alliance pharmacy chain Boots. DeepX Health has so far preformed about 180 thousand teledermoscopy assessments of skin lesions through its services offered to concerned consumers and doctors.

‍

For more information about DermoSight: www.dermosight.com

‍